The Global Fund to Fight AIDS, Tuberculosis and Malaria on Friday appealed to international donors to join them in an effort to fight medicine theft, SAPA/News24 reports.
Access to Health Services
Also In Global Health News: Clinical Trial Participants Abroad; PMTCT Project In Malawi; Congo Polio Outbreak; Global Fund Zambia Grant; Women, Girls In Afghanistan
Lancet World Report Examines Protections In Place For Clinical Trial Participants Abroad Lancet World Report, in a follow-up on the revelations over the U.S.’s role in medical experiments conducted on Guatemalan prisoners in the 1940s writes: “A thorough review of the safeguards in place to protect modern human trial participants…
Rate Of Health Care-Associated Infections In Developing Countries More Than Double U.S., European Rates, Study Finds
The rate of health care-associated infections in developing countries is more than three times the rate of cases in the U.S. and more than double the rate in Europe, according to a study published Friday in the Lancet, BBC reports (12/9).
EU, India Leaders Meet To Discuss Trade Deal, Some Concerned Deal Will Jeopardize Drug Access In Developing Countries
On Friday, Indian Commerce Minister Anand Sharma and EU Trade Commissioner Karel de Gucht met to “present a status report on the ongoing free trade talks” that some health advocates fear could limit the supply of generic medications in developing countries, according to Business Standard. “An EU source said the report would signal that talks had made excellent progress and should be wrapped up by early next year,” according to the news service (Aiyar, 12/10).
Haiti’sÂ Water Needs: Though “cholera epidemics of the 19th century forged the way for the revolution in sanitation and the provision of safe sources of public water, â€¦ more than 1 billion people â€¦ have little access to safe sources of water,” write the authors of a Lancet Comment that reflects…
The World Program Program (WFP), with the support of UNAIDS, is planning to launch “a new policy to make food and nutritional support more available to people living with HIV,” VOA News reports. The agency “says the aim of [the] program is to help patients stick to their treatment, while protecting their households from further vulnerability,” the news service adds.
Also In Global Health News: Cholera In Haiti; Food In Ghana; Health Care Access In Afghanistan; Violence Against Women In Somalia; Male Circumcision Study
CDC Report Documents Cholera’s Spread In Haiti Haiti’s cholera outbreak has spread across the country and infected more than 91,000 people, while more than 2,000 people have died as a result, the CDC said in its Morbidity and Mortality Weekly Report, which was published on Wednesday, the Los Angeles Times…
National Institutes of Health (NIH) Director Francis Collins on Tuesday announced the agency is moving forward on plans to create a new research center focused on translational science, after NIH’s advisory board voted to create the new center, Science’s “Science Insider” reports (Kaiser, 12/7).
India, EU Trade Agreement Will Not Restrict Ability For India Pharmaceutical Firms To Export Generic Drugs, Official Says
“India and the European Union (EU) have agreed that the comprehensive bilateral trade agreement being negotiated by the two will not result in an intellectual property regime that restricts the ability of Indian pharmaceutical firms to export generic or off-patent drugs by being far more stringent than the TRIPS [Trade-Related Aspects of International Property Rights] regime of the World Trade Organization,” LiveMint.com reports in an article that describes recent debates over the agreement. “The two sides agreed to this at a meeting between Indian trade minister Anand Sharma and his counterpart in the European Commission (EC), Karel De Gucht, at Brussels on 29 November, said a senior commerce ministry official on condition of anonymity,” the news service reports.
HP and the African social enterprise mPedigree on Monday announced a new service that will enable patients in Ghana and Nigeria to verify the authenticity of their medications, Fast Company reports. “Counterfeit drugs are estimated to be a $75-billion-per-year business, [and are] implicated in the deaths of something like 700,000 people around the world annually,” according to the article (Zax, 12/6).